← Leaderboards
Sue Ellen Abdalian
Tulane University Of Louisiana
$10,492,722
Attributed
$10,492,722
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,492,722 · 14
By mechanism
U01$8,981,791 · 2
UM2$1,424,824 · 2
M01$86,107 · 10
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Huanbin Xu$8,118,275
- Qi Zhao$10,546,941
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsHiv InfectionsCollaborationsAdolescent Medicine Trials NetworkYouthCommunitiesAdolescent MedicineAids/Hiv ProblemHuman SubjectAdolescentProgramsResearch InfrastructureProtocols DocumentationResearch PersonnelAcquired Immunodeficiency SyndromeClinical Research SiteAdolescence (12-20)EthicsAffectSex BehaviorAidsHealth BehaviorAids /Hiv DiagnosisBase
Grant awards (33)
The Administrators of the Tulane Educational Fund dba TUHSC Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Tri$303,289
UM2 · FY2025 · HD · contact PI
The Administrators of the Tulane Educational Fund dba TUHSC Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Tri$480,604
UM2 · FY2024 · HD · contact PI
The Administrators of the Tulane Educational Fund dba TUHSC Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Tri$320,774
UM2 · FY2023 · HD · contact PI
The Administrators of the Tulane Educational Fund dba TUHSC Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Tri$320,157
UM2 · FY2022 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$518,980
U01 · FY2015 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$653,137
U01 · FY2014 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$619,112
U01 · FY2013 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$633,378
U01 · FY2012 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$624,297
U01 · FY2011 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$610,256
U01 · FY2010 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$598,463
U01 · FY2009 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$581,030
U01 · FY2008 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$302,802
U01 · FY2007 · HD · contact PI
New Orleans Adolescent Medicine Trials Unit$91,280
U01 · FY2006 · HD · contact PI
HEPATITIS B VACCINATION IN YOUTH AT ATN SITES: EFFECTIVENESS OF TWO STRATEGIES$11,284
M01 · FY2006 · RR · contact PI
EVALUATION OF HIV-SPECIFIC CD8+ T-CELL RESPONSES IN DISEASE PROGRESSION$7,253
M01 · FY2006 · RR · contact PI
THE IMPACT OF VIRAL LOAD SUPPRESSION IN ADOLESCENTS$6,448
M01 · FY2006 · RR · contact PI
OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION SCHEMAS IN HIV-POSITIVE YOUTH$6,448
M01 · FY2006 · RR · contact PI
ATN021:PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED$4,030
M01 · FY2006 · RR · contact PI
NEW ORLEANS ADOLESCENT MEDICINE TRIALS UNIT$989,167
U01 · FY2005 · HD
ATN021:PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED$11,896
M01 · FY2005 · RR
EVALUATION OF HIV-SPECIFIC CD8+ T-CELL RESPONSES IN DISEASE PROGRESSION$8,204
M01 · FY2005 · RR
HEPATITIS B VACCINATION IN YOUTH AT ATN SITES: EFFECTIVENESS OF TWO STRATEGIES$3,692
M01 · FY2005 · RR
OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION SCHEMAS IN HIV-POSITIVE YOUTH$1,231
M01 · FY2005 · RR
NEW ORLEANS ADOLESCENT MEDICINE TRIALS UNIT$555,436
U01 · FY2004 · HD
EVALUATION OF HIV-SPECIFIC CD8+ T-CELL RESPONSES$12,275
M01 · FY2004 · RR
ATN021:PREVALENCE OF MORPHOLOGIC/METABOLIC ABNORMALITIES$2,166
M01 · FY2004 · RR
NEW ORLEANS ADOLESCENT MEDICINE TRIALS UNIT$915,800
U01 · FY2003 · HD
NEW ORLEANS ADOLESCENT MEDICINE TRIALS UNIT$762,602
U01 · FY2002 · HD
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS$347,686
U01 · FY2001 · HD
NEW ORLEANS ADOLESCENT HIV/AIDS RESEARCH PROGRAM--REACH PROJECT$0
M01 · FY2001 · RR
ADOLESCENT MEDICINE HIV/AIDS RESEARCH NETWORK$178,365
U01 · FY2000 · HD
NEW ORLEANS ADOLESCENT HIV/AIDS RESEARCH PROGRAM--REACH PROJECT$11,180
M01 · FY2000 · RR